Craft

BGM Group

Stock Price

$7.2

2024-10-11

Market Capitalization

$38.7 M

2024-10-11

Revenue

$25.1 M

FY, 2024

BGM Group Summary

Company Summary

Overview
BGM Group (formerly Qilian International Holding) is a pharmaceutical and chemical company. It  focuses on the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers.
Type
Public
Status
Active
Founded
2019
HQ
Jiuquan, CN | view all locations
Website
https://www.bgmgroupltd.com/
Cybersecurity rating
Sectors

Key People

  • Haiping Shi

    Haiping Shi, Chief Financial Officer and Director

    Operating MetricsView all

    Properties

    11

    H1, 2020

    Product Categories

    5

    H1, 2020

    Products

    10

    H1, 2020

    LocationsView all

    1 location detected

    • Jiuquan, Gansu HQ

      China

      Jiuquan Economic and Technological Development Zone

    BGM Group Financials

    Summary Financials

    Revenue (H1, 2025)
    $14.3M
    Gross profit (H1, 2025)
    $3.0M
    Net income (H1, 2025)
    ($825.0K)
    Cash (H1, 2025)
    $9.7M
    EBIT (H1, 2025)
    ($1.7M)
    Enterprise value
    $30.6M

    Footer menu